Evaluation of zoledronate for the treatment of canine stage III osteosarcoma: A phase II study.

Ashley A SmithStephanie E S LindleyGreg T AlmondNoelle S BergmanBrad M MatzAnnette N Smith

Published in: Veterinary medicine and science (2022)

Zoledronate appears to have limited efficacy as a single agent for stage III osteosarcoma and may be associated with unexpected toxicity in this population. This clinical trial was registered on the AVMA Animal Health Studies Database (AAHSD004396).

Keyphrases

phase ii study
clinical trial
open label
healthcare
public health
locally advanced
mental health
oxidative stress
phase ii
study protocol
health information
risk assessment
radiation therapy
double blind
rectal cancer
phase iii
placebo controlled
climate change
combination therapy